EDGAR Filing Documents for 0001047469-18-001688

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-18-001688

Filing Date

2018-03-15

Accepted

2018-03-15 16:02:34

Documents

Period of Report

2017-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2234670z10-k.htm	10-K	1513627
2	EX-23.1	a2234670zex-23_1.htm	EX-23.1	3906
3	EX-31.1	a2234670zex-31_1.htm	EX-31.1	7938
4	EX-31.2	a2234670zex-31_2.htm	EX-31.2	7950
5	EX-32.1	a2234670zex-32_1.htm	EX-32.1	4438
6	EX-32.2	a2234670zex-32_2.htm	EX-32.2	4479
13	G755106.JPG	g755106.jpg	GRAPHIC	66484
14	G709887.JPG	g709887.jpg	GRAPHIC	56184
	Complete submission text file	0001047469-18-001688.txt		7264210

Data Files

Seq	Description	Document	Type	Size
7	EX-101.INS	catb-20171231.xml	EX-101.INS	1671362
8	EX-101.SCH	catb-20171231.xsd	EX-101.SCH	48096
9	EX-101.CAL	catb-20171231_cal.xml	EX-101.CAL	55323
10	EX-101.LAB	catb-20171231_lab.xml	EX-101.LAB	488028
11	EX-101.PRE	catb-20171231_pre.xml	EX-101.PRE	366241
12	EX-101.DEF	catb-20171231_def.xml	EX-101.DEF	191357

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)